Ticagrelor and Tendonitis - a phase IV clinical study of FDA data

Summary:

Tendonitis is reported as a side effect among people who take Ticagrelor (ticagrelor), especially for people who are male, 60+ old, also take Synthroid, and have Secondary adrenocortical insufficiency.

The phase IV clinical study analyzes which people have Tendonitis when taking Ticagrelor. It is created by eHealthMe based on reports of 8,473 people who have side effects when taking Ticagrelor from the FDA, and is updated regularly.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 8,499 Ticagrelor users. Check the latest studies of Ticagrelor.

What is Tendonitis?

Tendonitis (a condition that causes pain and swelling of tendons) is found to be associated with 1,096 drugs and 1,273 conditions by eHealthMe. Check the latest studies of Tendonitis.

On Aug, 05, 2026

8,473 people reported to have side effects when taking Ticagrelor.
Among them, 23 people (0.27%) have Tendonitis.

Among these 23 people:

What is the gender of people who have Tendonitis when taking Ticagrelor? *

female: 10 %
male: 90 %

What is the age of people who have Tendonitis when taking Ticagrelor? *

What are other drugs people take besides Ticagrelor? *

What are other side effects people have besides Tendonitis? *

Weakness: 19 people, 82.61%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 17 people, 73.91%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 17 people, 73.91%
Bone Disorder: 17 people, 73.91%
Cardiac Disorder: 17 people, 73.91%
Pain: 17 people, 73.91%
Chronic Kidney Disease: 17 people, 73.91%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 17 people, 73.91%
Hypersensitivity: 14 people, 60.87%
Ectropion (lower eyelid turns outwards): 2 people, 8.70%

What are the existing conditions these people have? *

Wound: 17 people, 73.91%
Nodule (a growth of abnormal tissue): 17 people, 73.91%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 17 people, 73.91%
Itching: 17 people, 73.91%
Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 17 people, 73.91%
Pain: 17 people, 73.91%
Secondary Adrenocortical Insufficiency (inadequate secretion of acth by the pituitary gland): 17 people, 73.91%
Growth Hormone Deficiency: 16 people, 69.57%
Infarction (obstruction of the blood supply to an organ or region of tissue): 2 people, 8.70%
Infective Exacerbation Of Bronchiectasis (severe infective lung disease): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and have Tendonitis?

- Check whether Tendonitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ticagrelor:

Ticagrelor (8,499 reports)

Tendonitis treatments and more:

Tendonitis (23,484 reports)

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tendonitis:

Tendonitis (1,096 drugs)

Browse all the conditions that are associated with Tendonitis:

Tendonitis (1,273 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Ticagrelor) and Ticagrelor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.